Published in Gut on July 01, 1999
Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease? Dig Dis Sci (2004) 1.51
Does Helicobacter pylori infection play a role in iron deficiency anemia? A meta-analysis. World J Gastroenterol (2010) 1.34
Helicobacter pylori infection and respiratory diseases: a review. World J Gastroenterol (2003) 1.06
Third-line rescue therapy for Helicobacter pylori infection. World J Gastroenterol (2006) 1.02
Stomach bugs and diabetes: an astounding observation or just confounding? Diabetes Care (2012) 0.92
Screening test for anti-Helicobacter pylori activity of traditional Chinese herbal medicines. World J Gastroenterol (2010) 0.92
Chlamydia pneumoniae and Helicobacter pylori IgG seropositivities are not predictors of osteoporosis-associated bone loss: a prospective cohort study. J Bone Miner Metab (2015) 0.88
Increased levels of Helicobacter pylori IgG antibodies in aqueous humor of patients with primary open-angle and exfoliation glaucoma. Graefes Arch Clin Exp Ophthalmol (2003) 0.88
Role of Helicobacter pylori infection on nutrition and metabolism. World J Gastroenterol (2014) 0.88
Impact of Lactobacillus reuteri Supplementation on Anti-Helicobacter pylori Levofloxacin-Based Second-Line Therapy. Gastroenterol Res Pract (2012) 0.87
Cure of alopecia areata after eradication of Helicobacter pylori: a new association? World J Gastroenterol (2011) 0.86
Helicobacter pylori seroprevalence in patients with lung cancer. World J Gastroenterol (2004) 0.86
Diffuse duodenal nodular lymphoid hyperplasia: a large cohort of patients etiologically related to Helicobacter pylori infection. BMC Gastroenterol (2011) 0.83
Hematologic manifestations of Helicobacter pylori infection. World J Gastroenterol (2014) 0.83
Frequency of Helicobacter pylori and cytotoxine associated gene A antibodies in patients with cardiac syndrome X. J Cardiovasc Dis Res (2012) 0.81
Helicobacter pylori infection is associated with greater impairment of cytochrome P-450 liver metabolic activity in anti-HCV positive cirrhotic patients. Dig Dis Sci (2003) 0.79
Regression of Helicobacter pylori-negative duodenal ulcers complicated by Schonlein-Henoch purpura with H. pylori eradication therapy: the first report. Dig Dis Sci (2005) 0.79
Gastrointestinal disorders associated with migraine: A comprehensive review. World J Gastroenterol (2016) 0.77
Helicobacter pylori in patients suffering from pulmonary disease. Tanaffos (2011) 0.76
Gastric mucosa: long-term outcome after cure of Helicobacter pylori infection. J Gastroenterol (2002) 0.76
Current views of the relationship between Helicobacter pylori and Henoch-Schonlein purpura in children. World J Clin Pediatr (2016) 0.76
Helicobacter pylori and cardiovascular complications: a mechanism based review on role of Helicobacter pylori in cardiovascular diseases. Integr Med Res (2016) 0.75
Association between Helicobacter Pylori Infection and Alopecia Areata: A Study in Iranian Population. Middle East J Dig Dis (2017) 0.75
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med (1997) 18.85
Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet (1988) 7.59
Chronic infections and coronary heart disease: is there a link? Lancet (1997) 7.18
Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology (1998) 4.30
Group A streptococcal infections and acute rheumatic fever. N Engl J Med (1991) 4.20
Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J (1994) 3.13
Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation (1998) 2.75
Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart (1997) 2.50
Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet (1998) 2.15
Regression of mucosa-associated lymphoid-tissue lymphoma of rectum after eradication of Helicobacter pylori. Lancet (1997) 1.94
Regression of salivary gland MALT lymphoma after treatment for Helicobacter pylori. Lancet (1996) 1.91
Helicobacter pylori gastric infection and sideropenic refractory anemia. J Pediatr Gastroenterol Nutr (1993) 1.89
Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology (1996) 1.83
Beneficial effects of Helicobacter pylori eradication on idiopathic chronic urticaria. Dig Dis Sci (1998) 1.61
Monoclonal antibodies against Helicobacter pylori cross-react with human tissue. Helicobacter (1997) 1.54
Is Helicobacter pylori of interest to ophthalmologists? Ophthalmology (1997) 1.41
Helicobacter pylori infection and growth delay in older children. Arch Dis Child (1997) 1.39
Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study. BMJ (1997) 1.34
Persistent infection and vascular disease: a systematic review. Expert Opin Investig Drugs (1998) 1.30
Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not. Epidemiol Infect (1998) 1.24
Proposed link between Helicobacter pylori and sudden infant death syndrome. Med Hypotheses (1997) 1.07
High prevalence of Helicobacter pylori in liver cirrhosis: relationship with clinical and endoscopic features and the risk of peptic ulcer. Dig Dis Sci (1997) 1.03
Effects of Helicobacter pylori eradication therapy on hyperammonaemia in patients with liver cirrhosis. Gut (1997) 1.03
Beneficial effects of Helicobacter pylori eradication on migraine. Hepatogastroenterology (1998) 1.02
Reversal of long-standing iron deficiency anaemia after eradication of Helicobacter pylori infection. Scand J Gastroenterol (1997) 1.02
Helicobacter pylori infection is related to atheroma in patients undergoing coronary angiography. Cardiovasc Res (1997) 1.00
Helicobacter pylori infection: a risk factor for ischaemic cerebrovascular disease and carotid atheroma. J Neurol Neurosurg Psychiatry (1998) 0.99
Schönlein-Henoch purpura associated with gastric Helicobacter pylori infection. J Am Acad Dermatol (1995) 0.97
Most Helicobacter pylori-infected patients have specific antibodies, and some also have H. pylori antigens and genomic material in bile: is it a risk factor for gallstone formation? Dig Dis Sci (1998) 0.97
Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori. Lancet (1997) 0.96
Editorial: Viruses and arteriosclerosis. Am Heart J (1974) 0.93
Schönlein-Henoch purpura associated with gastric Helicobacter pylori infection. Dermatology (1997) 0.91
Helicobacter pylori antigen in the glomeruli of patients with membranous nephropathy. Virchows Arch (1997) 0.91
Helicobacter pylori infection and chronic urticaria. J Am Acad Dermatol (1996) 0.90
Helicobacter pylori gastritis and sideropenic refractory anemia. J Pediatr Gastroenterol Nutr (1997) 0.85
Coronary artery disease associated with Helicobacter pylori infection is at least partially due to inadequate folate status. Med Hypotheses (1997) 0.82
May Helicobacter pylori be important for dermatologists? Dermatology (1995) 0.81
Helicobacter pylori and diminished growth in children: is it simply a marker of deprivation? Ital J Gastroenterol Hepatol (1998) 0.81
Prospective study of Helicobacter pylori seropositivity and cardiovascular diseases in a general elderly population. BMJ (1997) 0.80
Gastric juice levels of lactoferrin and Helicobacter pylori infection. Scand J Gastroenterol (1997) 0.80
Chlamydia pneumoniae and Helicobacter pylori infections in Sámi and Finnish reindeer herders. Int J Circumpolar Health (1997) 0.80
A study of the prevalence of Helicobacter pylori infection and other markers of upper gastrointestinal tract disease in patients with rosacea. Am J Gastroenterol (1998) 0.78
Acute immune polyneuropathies: correlations of serum antibodies to Campylobacter jejuni and Helicobacter pylori with anti-GM1 antibodies and clinical patterns of disease. J Infect Dis (1997) 0.77
Helicobacter pylori and the liver: any relationship? Ital J Gastroenterol Hepatol (1998) 0.77
Structure of functionally activated small ribosomal subunit at 3.3 angstroms resolution. Cell (2000) 12.43
High resolution structure of the large ribosomal subunit from a mesophilic eubacterium. Cell (2001) 6.97
Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature (2001) 6.40
Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group. Lancet (1999) 5.27
Crystal structures of complexes of the small ribosomal subunit with tetracycline, edeine and IF3. EMBO J (2001) 3.68
Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation (1998) 2.75
Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther (2009) 2.41
The diagnosis of small bowel bacterial overgrowth. Reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology (1990) 2.32
Endoscopic demonstration of loss of duodenal folds in the diagnosis of celiac disease. N Engl J Med (1988) 2.27
Screening test for coeliac disease. Lancet (1997) 2.23
Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet (1998) 2.15
Detection of malabsorption of low doses of carbohydrate: accuracy of various breath H2 criteria. Gastroenterology (1993) 2.15
Onset of coeliac disease during treatment with interferon for chronic hepatitis C. Lancet (2000) 2.13
A case of pyoderma gangrenosum with ulcerative colitis treated with combined approach: infliximab and surgery. J Crohns Colitis (2012) 2.12
Randomised clinical trial: the efficacy and safety of propionyl-L-carnitine therapy in patients with ulcerative colitis receiving stable oral treatment. Aliment Pharmacol Ther (2011) 2.12
Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients. Cancer (1995) 2.11
Atrophic gastritis as a cause of hyperhomocysteinaemia. Aliment Pharmacol Ther (2004) 2.09
Hydrogen peroxide-related colitis (previously known as "pseudolipomatosis"): a series of cases occurring in an epidemic pattern. Endoscopy (2007) 2.07
Atypical sarcoidosis: case reports and review of the literature. Eur Rev Med Pharmacol Sci (2009) 1.98
Hormonal responses to whole-body vibration in men. Eur J Appl Physiol (2000) 1.92
Oral desensitizing treatment in food allergy: clinical and immunological results. Aliment Pharmacol Ther (2003) 1.88
Current European concepts in the management of Helicobacter pylori infection--the Maastricht Consensus Report. The European Helicobacter Pylori Study Group (EHPSG). Eur J Gastroenterol Hepatol (1997) 1.81
Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther (2005) 1.78
Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther (2006) 1.76
Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment Pharmacol Ther (2002) 1.73
Helicobacter pylori reinfection and rapid relapse of low-grade B-cell gastric lymphoma. Lancet (1995) 1.68
Body composition changes induced by chronic ethanol abuse: evaluation by dual energy X-ray absorptiometry. Am J Gastroenterol (2000) 1.63
Oral disodium cromoglycate treatment on irritable bowel syndrome: an open study on 101 subjects with diarrheic type. Am J Gastroenterol (1992) 1.62
Autoimmune enteropathy and villous atrophy in adults. Lancet (1997) 1.62
Beneficial effects of Helicobacter pylori eradication on idiopathic chronic urticaria. Dig Dis Sci (1998) 1.61
Prevalence and early diagnosis of coeliac disease in autoimmune thyroid disorders. Ital J Gastroenterol Hepatol (1999) 1.60
Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial. Aliment Pharmacol Ther (2003) 1.59
Bone mass and metabolism in patients with celiac disease. Gastroenterology (1995) 1.59
Endoscopic markers in adult coeliac disease. Dig Liver Dis (2002) 1.58
Serological screening of coeliac disease: choosing the optimal procedure according to various prevalence values. Gut (1994) 1.57
Methodology of the H2 breath test. II. Importance of the test duration in the diagnosis of carbohydrate malabsorption. Ital J Gastroenterol (1990) 1.55
Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth. Aliment Pharmacol Ther (2005) 1.54
Howell-Jolly body counting as a measure of splenic function. A reassessment. Clin Lab Haematol (1990) 1.54
Anticardiolipin antibodies in giant cell arteritis and polymyalgia rheumatica: a study of 40 cases. Br J Rheumatol (1998) 1.54
NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population. Aliment Pharmacol Ther (2003) 1.54
The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther (2001) 1.52
Ultrasonography in the diagnosis of portal hypertension: diminished response of portal vessels to respiration. Radiology (1982) 1.52
Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status. Scand J Gastroenterol (1997) 1.52
Epithelial-cell apoptosis and proliferation in Helicobacter pylori-related chronic gastritis. Ital J Gastroenterol Hepatol (1998) 1.50
Multifrequency bioelectrical impedance analysis in women with a normal and hypertensive pregnancy. Am J Clin Nutr (2000) 1.48
Anticholinergic syndrome due to 'Devil's herb': when risks come from the ancient time. Int J Clin Pract (2006) 1.45
A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy. Hepatology (1989) 1.43
Clinical nutrition practice in Italian Gastroenterology Units. Dig Liver Dis (2001) 1.42
Ageing affects anoxia/reoxygenation injury in rat hepatocytes. Scand J Gastroenterol (1998) 1.42
Treatment of primary sclerosing cholangitis with low-dose ursodeoxycholic acid: results of a retrospective Italian multicentre survey. Dig Liver Dis (2003) 1.42
Interferon alpha plus ketoprofen or interferon alpha plus ribavirin in chronic hepatitis C non-responder to interferon alpha alone: results of a pilot study. Ital J Gastroenterol Hepatol (1999) 1.41
Doppler ultrasound evaluation of acute effects of cigarette smoking on portal blood flow in man. J Gastroenterol Hepatol (1996) 1.40
Appearance of duodenal folds and untreated adult celiac disease. Gastrointest Endosc (1993) 1.39
Effect of a vegetable-protein-rich polymeric diet treatment on body composition and energy metabolism in inactive Crohn's disease. Eur J Gastroenterol Hepatol (2000) 1.39
Effects of Lactobacillus GG on genes expression pattern in small bowel mucosa. Dig Liver Dis (2005) 1.39
Subclinical coeliac disease is a frequent cause of iron-deficiency anaemia. Scand J Gastroenterol (1995) 1.39
[Whipple's disease: progress in the diagnosis and review of the literature]. Minerva Med (2002) 1.38
Acquired gastric mucosa-associated lymphoid tissue (MALT): a review with special emphasis on association with extragastric diseases and management problems of gastric MALT. J Clin Gastroenterol (1999) 1.38
Ability of baclofen in reducing alcohol craving and intake: II--Preliminary clinical evidence. Alcohol Clin Exp Res (2000) 1.38
Apparent association constants of tRNAs for the ribosomal A, P, and E sites. J Biol Chem (1992) 1.36
Bacteroides thetaiotaomicron in the gut: molecular aspects of their interaction. Dig Liver Dis (2007) 1.36
DR and non-DR Ia allotypes are associated with susceptibility to coeliac disease. Gut (1985) 1.35
The small ribosomal subunit from Thermus thermophilus at 4.5 A resolution: pattern fittings and the identification of a functional site. Proc Natl Acad Sci U S A (1999) 1.33
Gastrointestinal amyloidosis: a case of chronic diarrhoea. Eur Rev Med Pharmacol Sci (2009) 1.31
Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency. Diabetes (1999) 1.31
Quantitative assessment of the mucosal architecture of jejunal biopsy specimens: a comparison between linear measurement, stereology, and computer aided microscopy. J Clin Pathol (1985) 1.30
Anisakis infestation: a case of acute abdomen mimicking Crohn's disease and eosinophilic gastroenteritis. Dig Liver Dis (2005) 1.27
Insulin resistance directly correlates with increased saturated fatty acids in skeletal muscle triglycerides. Metabolism (2000) 1.27
Adduct formation between alkali metal ions and divalent metal salicylaldimine complexes having methoxy substituents. A structural investigation. Inorg Chem (2000) 1.27
Noninvasive antigen-based assay for assessing Helicobacter pylori eradication: a European multicenter study. The European Helicobacter pylori HpSA Study Group. Am J Gastroenterol (2000) 1.26
Prevalence and clinical presentation of subclinical/silent celiac disease in adults: an analysis on a 12-year observation. Hepatogastroenterology (2001) 1.25
Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection. Aliment Pharmacol Ther (2000) 1.24
State and trait anxiety and depression in patients affected by gastrointestinal diseases: psychometric evaluation of 1641 patients referred to an internal medicine outpatient setting. Int J Clin Pract (2008) 1.23
Crystallographic studies on the ribosome, a large macromolecular assembly exhibiting severe nonisomorphism, extreme beam sensitivity and no internal symmetry. Acta Crystallogr A (1998) 1.21
Subclinical celiac sprue. Increasing occurrence and clues to its diagnosis. J Clin Gastroenterol (1993) 1.20
Characterization of MSH2 and MLH1 mutations in Italian families with hereditary nonpolyposis colorectal cancer. Genes Chromosomes Cancer (1997) 1.20
Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome. Aliment Pharmacol Ther (2005) 1.19
Liver transplantation: the Italian experience. Dig Liver Dis (2002) 1.19
Review article: breath testing for human liver function assessment. Aliment Pharmacol Ther (2002) 1.19
Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up. Aliment Pharmacol Ther (2007) 1.18
Visualization of unwinding activity of duplex RNA by DbpA, a DEAD box helicase, at single-molecule resolution by atomic force microscopy. Proc Natl Acad Sci U S A (2001) 1.17
Gluten specific suppressor T cell dysfunction in coeliac disease. Gut (1986) 1.17